DNA Chip Research, Inc. (2397) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 1.08%

The company has been able to generate a Return on Equity (avg) of 1.08% signifying low profitability per unit of shareholders funds

With a growth in Net Sales of 36.7%, the company declared Outstanding results in Mar 25

Risky -

Consistent Returns over the last 3 years

Mojo Parameters

Stock DNA

Industry

Medical/Nursing Services

Market cap

JPY 7,390 Million (Small Cap)

P/E

203.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.61

Return on Equity

5.39%

Price to Book

10.96

Revenue and Profits:

Net Sales:

219 Million

(Quarterly Results - Mar 2024)

Net Profit:

-10 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-0.46%

6 Months

64.71%

1 Year

16.54%

2 Years

49.59%

3 Years

147.62%

4 Years

58.26%

5 Years

21.33%

DNA Chip Research, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

24.71%

EBIT Growth (5y)

18.35%

EBIT to Interest (avg)

-184.03

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.61

Sales to Capital Employed (avg)

0.91

Tax Ratio

5.06%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.02%

ROE (avg)

1.08%

Valuation key factors

Factor

Value

P/E Ratio

203

Industry P/E

Price to Book Value

10.95

EV to EBIT

175.42

EV to EBITDA

71.61

EV to Capital Employed

26.46

EV to Sales

6.39

PEG Ratio

1.77

Dividend Yield

ROCE (Latest)

15.09%

ROE (Latest)

5.39%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2024 is 36.70% vs -23.02% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2024 is 77.94% vs -223.54% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "219.00",
          "val2": "160.20",
          "chgp": "36.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.70",
          "val2": "-32.40",
          "chgp": "63.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "-3.20",
          "chgp": "84.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.30",
          "val2": "-46.70",
          "chgp": "77.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-103.10%",
          "val2": "-254.50%",
          "chgp": "15.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 49.77% vs -23.46% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 31.47% vs -170.37% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "490.50",
          "val2": "327.50",
          "chgp": "49.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-216.40",
          "val2": "-343.90",
          "chgp": "37.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "4.40",
          "chgp": "-111.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-248.30",
          "val2": "-362.30",
          "chgp": "31.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-526.50%",
          "val2": "-1,107.90%",
          "chgp": "58.14%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'24 - YoY

Mar'24

Mar'23

Change(%)

Net Sales

219.00

160.20

36.70%

Operating Profit (PBDIT) excl Other Income

-11.70

-32.40

63.89%

Interest

0.00

Exceptional Items

-0.50

-3.20

84.38%

Consolidate Net Profit

-10.30

-46.70

77.94%

Operating Profit Margin (Excl OI)

-103.10%

-254.50%

15.14%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2024 is 36.70% vs -23.02% in Mar 2023

Consolidated Net Profit

YoY Growth in quarter ended Mar 2024 is 77.94% vs -223.54% in Mar 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'24

Mar'24

Mar'23

Change(%)

Net Sales

490.50

327.50

49.77%

Operating Profit (PBDIT) excl Other Income

-216.40

-343.90

37.07%

Interest

0.00

Exceptional Items

-0.50

4.40

-111.36%

Consolidate Net Profit

-248.30

-362.30

31.47%

Operating Profit Margin (Excl OI)

-526.50%

-1,107.90%

58.14%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2024 is 49.77% vs -23.46% in Mar 2023

Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 31.47% vs -170.37% in Mar 2023

All Annual Results

Company CV

About DNA Chip Research, Inc.

DNA Chip Research, Inc.

Medical/Nursing Services

No Details Available.

Company Coordinates

No Company Details Available